Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Amgen Inc. (AMGN)

-NasdaqGS
158.30 Down 2.26(1.41%) Apr 29, 4:00PM EDT
|After Hours : 157.90 Down 0.40 (0.25%) Apr 29, 7:57PM EDT
Prev Close:160.56
Open:159.35
Bid:157.00 x 100
Ask:159.29 x 500
1y Target Est:182.06
Beta:1.24135
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:156.38 - 161.92
52wk Range:130.09 - 181.81
Volume:5,386,570
Avg Vol (3m):3,623,790
Market Cap:118.73B
P/E (ttm):17.47
EPS (ttm):9.06
Div & Yield:4.00 (2.49%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNDown 1.41%118.73B
JNJDown 0.36%309.15B

Key Statistics

Forward P/E (1 yr):13.01
P/S (ttm):5.57
Ex-Dividend Date:13-May-16

Analysts

Annual EPS Est (Dec-16) :11.09
Quarterly EPS Est (Jun-16) :2.76
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, engages in discovering, developing, manufacturing, and delivering human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback